Most Read Articles
Audrey Abella, 16 Oct 2019
The PD-1* inhibitor nivolumab showed significant survival benefit and a favourable safety profile than taxane chemotherapy in patients with unresectable advanced or recurrent oesophageal squamous cell carcinoma (OSCC) refractory or intolerant to previous fluoropyrimidine- and platinum-based chemotherapy, according to the findings of ATTRACTION-3** presented at ESMO 2019.
03 Oct 2019
Early enteral nutrition (EEN) speeds up the recovery of gastrointestinal function after laparoscopic common bile duct exploration (LCBDE), according to a study. However, EEN also increases complications such as diarrhoea and abdominal distension.
01 Sep 2019
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
26 Sep 2019
Use of proton pump inhibitors contributes to increased risk of cholangitis, a large cohort study suggests.

Eating red, processed meats does not increase risk of CD recurrence

13 Jul 2019

The consumption of red and processed meats does not seem to affect the likelihood of symptom relapse among Crohn’s disease (CD) patients in relapse, reports a recent study.

Researchers randomly assigned adults with CD to either a high- (≥2 servings per week; n=118; median age, 37.0 years; 74.6 percent female) or low- (≤1 serving per month; n=96; median age, 35.0 years; 80 percent female) red and processed meat diet. All participants were in remission and reported consumption levels at least once weekly. The study’s primary outcome was relapse in CD, defined as an increase in CD disease activity index scores or the need for surgery or new medication.

Symptomatic relapse of CD was detected in 62 percent of the participants, while 42 percent and 35 percent had moderate-to-severe or persistent recurrence, respectively. There were no significant differences in the unadjusted time to symptomatic relapse, time to moderate-to-severe symptomatic relapse or time to persistent relapse between the different study arms.

Stratified Cox regression analysis further showed that there was no significant link between consumption of red and processed meats and the likelihood of symptomatic relapse. However, baseline nutrient intake was significantly correlated with the risk of symptomatic relapse (hazard ratio, 13.46, 95 percent CI, 1.22–148.45; p=0.03).

“In this study, participants in the low-meat group reported consuming two or more servings of red and/or processed meat far less frequently than those in the high-meat group. Additionally, the low-meat group significantly decreased their average weekly red meat consumption during the study,” said researchers.

“Despite these clear differences in diets, there were no statistically significant differences in time to relapse for any of the outcomes, suggesting that reduction of red and processed meats does not reduce the risk of symptomatic CD relapse in patients with quiescent disease,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 16 Oct 2019
The PD-1* inhibitor nivolumab showed significant survival benefit and a favourable safety profile than taxane chemotherapy in patients with unresectable advanced or recurrent oesophageal squamous cell carcinoma (OSCC) refractory or intolerant to previous fluoropyrimidine- and platinum-based chemotherapy, according to the findings of ATTRACTION-3** presented at ESMO 2019.
03 Oct 2019
Early enteral nutrition (EEN) speeds up the recovery of gastrointestinal function after laparoscopic common bile duct exploration (LCBDE), according to a study. However, EEN also increases complications such as diarrhoea and abdominal distension.
01 Sep 2019
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
26 Sep 2019
Use of proton pump inhibitors contributes to increased risk of cholangitis, a large cohort study suggests.